EN DE

Cscec Scimee Sci.&Tech. Co (300425) Fair Value & Analysis

Industrials · CN · Market cap 2.8B CNY

CS Cscec Scimee Sci.&Tech. Co 300425 · SHE
Price¥4.07
Fair Value¥0.5000
Upside-87.7%
Quality47/100
Watch Cscec Scimee Sci.&Tech. Co for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 0.9% net margin
Low debt · generates free cash flow
0.10% dividend yield
Trails peers (2/14)
Narrow moat 23/100
Evidence: Medium Range ¥0.2900 – ¥0.6800 Share as image

Fair value as of: Jul 9, 2026

From 25 valuation models · updated 32 days ago

Fair value updated Jul 9, 2026, revised from ¥1.06 to ¥0.5000 (−52.8%) since Jun 24, 2026. Share price +5.4% over the past month.

Below-average quality, and screening another 88% overvalued on our models.

What matters now

  • The price sits above even our optimistic bull case (¥0.6800). The favourable scenario is already priced in.
  • Solid but not exceptional quality (47/100) and above fair value, neither a clear bargain nor a standout compounder.
  • A fairly wide model range (¥0.2900 to ¥0.6800) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

¥6.77 ¥3.68 Fair Value ¥0.5000 Feb 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 9, 2026.

How to read this chart

60‑month range ¥3.68 – ¥6.77 · fair‑value band ¥0.2900 – ¥0.6800 · the ¥4.07 price screens above the ¥0.5000 fair value. Dashed = 300-day average. As of Jul 9, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Cscec Scimee Sci.&Tech. Co (300425) currently trades at ¥4.07, while our model-based Fair Value estimate is ¥0.5000, implying the stock looks roughly 87.7% overvalued today. The Quality Score stands at 47/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).

Over the trailing twelve months, Cscec Scimee Sci.&Tech. Co generated revenue of 1.6B CNY at a net margin of 0.9%. Revenue declined 0.3% year over year. It earns a return on equity of 0.7%. Net debt stands at 444M CNY. Fundamentals as of Jul 9, 2026

Our scenario range runs from ¥0.2900 (bear case) to ¥0.6800 (bull case); at ¥4.07, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 30% below its 52-week high and 1% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -48% fair-value upside, at -88%, 300425 screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF ¥2.01 ¥3.25 ¥5.17 80
Residual Income ¥2.31 ¥2.15 ¥1.46 76
Rev-Margin DCF ¥1.49 ¥2.36 ¥3.44 74
All 25 models by family
DCF Models
FCF DCF ¥2.02 ¥3.34 ¥5.44 38
5Y Revenue Exit ¥1.49 ¥2.36 ¥3.49 39
5Y EBITDA Exit ¥2.37 ¥4.11 ¥6.23 41
5Y P/E Exit ¥0.9000 ¥1.18 ¥1.46 38
10Y Revenue Exit ¥1.62 ¥2.48 ¥3.69 36
10Y EBITDA Exit ¥2.22 ¥3.71 ¥5.86 37
10Y P/E Exit ¥1.28 ¥1.65 ¥2.09 35
Earnings-Based
Graham-Dodd ¥0.1200 ¥0.5000 ¥0.6800 54
Lynch FV ¥0.1300 ¥0.1800 ¥0.2300 50
PEG = 1.0 ¥0.1300 ¥0.1800 ¥0.2300 46
EPV ¥1.13 ¥1.30 ¥1.45 59
Dividend Discount
Gordon GGM ¥0.5300 ¥1.05 ¥1.59 70
DDM Multi-Stage ¥0.5300 ¥0.9100 ¥1.11 61
Multiples
P/E Multiple ¥0.2900 ¥0.3800 ¥0.4800 63
P/S Multiple ¥0.2300 ¥0.3100 ¥0.3900 58
P/B Multiple ¥0.2300 ¥0.3100 ¥0.3900 55
EV/EBIT ¥1.73 ¥2.30 ¥2.86 53
EV/EBITDA ¥2.82 ¥3.74 ¥4.66 54
EV/Revenue ¥1.25 ¥1.77 ¥2.28 43
Asset-Based
NCAV (Graham) ¥1.73 ¥2.32 ¥3.47 50
Growth DCF
Growth DCF ¥2.01 ¥3.25 ¥5.17 80
Rev-Margin DCF ¥1.49 ¥2.36 ¥3.44 74
Economic Profit
Residual Income ¥2.31 ¥2.15 ¥1.46 76
ROIC Compounder ¥1.13 ¥1.30 ¥1.45 72
Growth Earnings
Growth-Adj P/E ¥0.2200 ¥0.3100 ¥0.4100 68

Widest divergence: DCF Models (¥2.48) versus Earnings-Based (¥0.1800). Highest evidence: Growth DCF (80).

Notify me when 300425 reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 1.6B CNY
Revenue growth (YoY) -0.3%
Net margin 0.9%
Return on equity 0.7%
Free cash flow 115M CNY FY2025
P/E ratio 203.5
More key figures
Operating margin 2.5%
EPS (TTM) ¥0.0200
Dividend yield 0.1%
EPS growth (YoY) -57.8%
Net debt 444M CNY FY2025

Figures from reported company fundamentals · as of Jul 9, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 47/100

Of which business quality 47 · Market factors (momentum, volatility) 34

Profitability 17
Margins and returns on capital today
Quality Growth 24
Are margins and returns improving?
Cashflow 55
Earnings quality: real cash, not paper profit
Fin. Strength 48
Balance sheet, leverage, solvency risk
Investment 79
Disciplined investing over empire-building
Low Volatility 88
Calm price path (market factor)
Momentum 14
Price trend over the last 3–12 months (market factor)
52W Momentum 5
Distance to the 52-week high (market factor)
Net Issuance 78
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Cscec Scimee Sci.&Tech. Co.,Ltd manufactures and sells environmental protection equipment and services in China. The company operates through Water treatment business, Centrifuge Business, and Municipal Wastewater Business segments.

Full company description

Cscec Scimee Sci.&Tech. Co.,Ltd manufactures and sells environmental protection equipment and services in China. The company operates through Water treatment business, Centrifuge Business, and Municipal Wastewater Business segments. It offers magnetic medium coagulation and sedimentation integrated equipment; rainwater interception and storage system; micro-oxygen rapid clarification reaction precipitation integrated equipment; low-carbon and high-efficiency denitrification integrated reactor; and sludge low temperature drying equipment. The company also provides internal inlet non-metallic perforated grille; PLD series of high-efficiency, energy-saving and intelligent centrifugal filtration equipment; high-efficiency sand and slag removal equipment; and high-efficiency swirl velocity separation technology systems. The company was formerly known as Scimee Sci.&Tech. Co.,Ltd and changed its name to Cscec Scimee Sci.&Tech. Co.,Ltd in October 2019. It operates in municipal sewage treatment, river basin water treatment and industrial wastewater treatment business fields. The company was founded in 2002 and is based in Chengdu, China.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Cscec Scimee Sci.&Tech. Co reported revenue of ¥1.6B in FY2025 versus ¥1.5B in FY2021, a compound +2.1%/yr. Reported net income was ¥12.4M in FY2025, compounding −48.8%/yr from FY2021.

Growth Quality 64/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
1.6B CNY
Latest YoY
+3.3%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
−2.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.0%
Avg. growth/yr (14Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+15.4%
Revenue +2.1%/yr
FY21 ¥1.5B
FY22 ¥1.7B
FY23 ¥1.7B
FY24 ¥1.5B
FY25 ¥1.6B
Net income −48.8%/yr
FY21 ¥180M
FY22 ¥192M
FY23 ¥167M
FY24 ¥88.2M
FY25 ¥12.4M
Character of growth · EPS growth decomposed (2013-2024) +7.2 % p.a.
Revenue per share +17.6 pp

of which total revenue +22.4 pp · buybacks/dilution −4.9 pp

EBIT margin −7.7 pp
Tax rate +0.5 pp
Residual (interest, one-offs) −3.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

300425 screens 88% overvalued. Compare with Veralto Corporation →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Cscec Scimee Sci.&Tech. Co Fair Value". https://www.fairvalue-calculator.com/stock/300425

Peer Group

Pollution & Treatment Controls · 91 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 47 · Below median
Fair Value upside −88% · Bottom 25%
Return on equity (TTM) 1% · Below median
Return on assets 0% · Below median
Net margin (TTM) 1% · Below median
Operating margin (TTM) 2% · Below median
Revenue growth -0% · Below median
Dividend yield (TTM) 0.1% · Bottom 25%
Debt / equity 0.12× · Higher than median

Valuation Multiples vs Pollution & Treatment Controls median · lower = cheaper

P/E (TTM) 203.5× · Pricier than 75% of peers
P/B 1.17× · Cheaper than median
P/S (TTM) 1.75× · Pricier than median
P/FCF 3.6× · Cheaper than median
EV/EBITDA 22.2× · Pricier than 75% of peers

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 0 · sector 0
FUTURE 0 · sector 14
PAST 3 · sector 10
HEALTH 94 · sector 95
DIVIDEND 2 · sector 37

VALUE 0: the price sits above our fair-value range.

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Pollution & Treatment Controls stocks, each showing price versus our Fair Value estimate (as of Jul 9, 2026).

Stock Price Fair Value vs Fair Value
Veralto Corporation VLTO $94.21 $69.11 -27%
Zurn Elkay Water Solutions Corporation ZWS $47.63 $24.92 -48%
Canmax Technologies Co 300390 ¥57.02 ¥10.41 -82%
CECO Environmental Corp CECO $83.63 $15.19 -82%
Fujian Longking Co 600388 ¥17.58 ¥15.59 -11%
Munters Group MTRS kr 166.60 kr 16.90 -90%
China Conch Venture Holdings 0586 HK$8.83 HK$14.14 +60%
Mega Union Technology Inc 6944 1,005 TWD 539.58 TWD -46%
MayAir Technology (China) Co 688376 ¥96.57 ¥18.80 -81%
Shanghai Emperor of Cleaning Hi-Tech Co 603200 ¥38.97 ¥5.73 -85%

Compare Cscec Scimee Sci.&Tech. Co with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Industrials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Cscec Scimee Sci.&Tech. Co (300425) overvalued or undervalued?
As of Jul 9, 2026, our model estimates a fair value of ¥0.5000 versus a price of ¥4.07, about −88% (overvalued).
What is the fair value of 300425?
Our model-based fair value for Cscec Scimee Sci.&Tech. Co is ¥0.5000 (as of Jul 9, 2026), built from audited fundamentals. The current price is ¥4.07.
What is the quality score of 300425?
Cscec Scimee Sci.&Tech. Co has a Quality Score of 47/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Cscec Scimee Sci.&Tech. Co (300425)?
Cscec Scimee Sci.&Tech. Co reported trailing-twelve-month revenue of about 1.6B CNY (latest available figure, as of Jul 9, 2026).
What is the net profit margin of 300425?
The net profit margin of Cscec Scimee Sci.&Tech. Co is about 0.9%, meaning it keeps roughly 0.9% of revenue as net income. Based on the latest reported figures.
Does Cscec Scimee Sci.&Tech. Co pay a dividend?
Cscec Scimee Sci.&Tech. Co currently shows a dividend yield of about 0.10% relative to its recent price (as of Jul 9, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Cscec Scimee Sci.&Tech. Co and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.